1. Domestic and foreign brands and market share of mammography machines
1. Brand introduction
The main manufacturers of domestic mammography machines are Shenzhen Shengnuo, HOLOGIC China (Beijing Haienkang), Shanghai New Huangpu, Lian Ying, Anke, Shanghai Kangda International, Wandong, Neusoft, Anjian, Prang, Lan Yun, Mei Novo, Huiying and other more than 20, of which the top installed capacity is HOLOGIC China, Shenguo, Lian Ying, Anke, Wandong.
There are more foreign brands. Many countries have locally produced mammography machines, most notably HOLOGIC, GE, SIMENS, PHILIPS, PLANMED, GIOTTO, TOSHIBA, FUJI, etc.
2. Market share analysis
.jpg)
Analysis of the price trend and causes of breast machines
1. Price trend:
The prices of low-end and mid-range products are getting lower and lower, and the high-tech features of technical barriers maintain high prices.
2. Reason:
The continuous growth of the mammary machine market has resulted in a particularly large number of manufacturers emerging in the short term.
Foreign surveys show that by 2020, the global mammary machine output is expected to reach 628 million US dollars. Europe is considered to be the largest market due to its good medical benefits and broad public awareness; the Asia Pacific region is considered to be the fastest growing region for mammography because of its large population, rapid economic growth and relatively blank market. .
.jpg)
Breast cancer is one of the most common malignant tumors in women. The incidence rate is 7-10% of all kinds of malignant tumors in the body. It has become one of the diseases that seriously threaten women's health. According to statistics, about 1.2 million women worldwide suffer from breast cancer every year, and 500,000 women die of breast cancer. The increase in the incidence rate has also led to a significant increase in mortality. With the development of China's national economy and the improvement of living standards, the incidence and mortality of breast cancer among women in China are increasing every year, and the situation is more serious in economically developed areas, which is close to the level of developed countries in Europe and America. With the launch of a new round of "two cancer screening" campaign initiated by the Ministry of Health and the All-China Women's Federation, the nation has once again set off a wave of attention to women's health and prevention of breast cancer in advance. In recent years, breast cancer patients in China have been characterized by youthfulness, high incidence and high mortality. At present, the mortality rate of breast cancer in the city has increased by 38.91%, which has become the first cause of death in gynecological tumors in China. If breast cancer can be detected and treated promptly before the cancer has metastasized, the cure rate can be as high as 95%.
Tiamulin Fumarate,Tiamulin Swine,Tiamulin Chicken,Tiamulin For Animal Use
Shandong Shengli Bioengineering Co., Ltd , https://www.shenglipharm.com